(ORR) and 92% disease control rate (DCR) observed with MICVO as monotherapy in 2L+ R/M HNSCC at 5.4 mg/kg 71% confirmed ORR and 100% DCR observed with MICVO in combination with KEYTRUDA® ...

MDNA11 demonstrates durable anti-tumor activity in phase-2 eligible expansion cohorts, enriched for immune checkpoint resistant melanoma, MSS endometrial cancer, MSI-H and TMB-H cancers, in each case ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...

Noblis MSD, a Noblis subsidiary and leading provider of science, technology and engineering services to the U.S. military, today announced that it has been awarded a $45 million contract to provide ...

MSD is expecting to see an additional $200 million layered onto its costs this year as a result of President Trump's tariffs – even before a possible pharma-specific levy is announced. The US pharma ...

MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

People like father Jacob Hamlin and his family have wound up in hardship as the agency pushes more people off long-term ...

“Following the initial pause, the FDA has placed the trial on a partial clinical hold,” the spokesperson explained.

Managing polymer melts and temperature variations is key to achieving product quality and operational efficiency.

The Girls' Frontline franchise is no stranger to branching out, but its newest spin-off, Girls' Frontline: Fire Control, feels like a step toward ushering in a new era for the long-running sci-fi ...

Surgical lasers must ensure clear pedal selection, instant shutoff on changes, and robust testing to prevent unintended ...

According to Mordor Intelligence, the aviation MRO software market is valued at USD 7.72 billion in 2025 and is expected to reach USD 9.56 billion by 2030, growing at a 4.37% CAGR. Growth is being ...